Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-230X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma ; volume:20 ; number:1 ; day:29 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
BMC gastroenterology ; 20, Heft 1 (29.6.2020), 1-9, 12.2020

Creator: Chen, Lei
Kan, Xuefeng
Sun, Tao
Ren, Yanqiao
Cao, Yanyan
Yan, Liangliang
Liang, Bin
Xiong, Bin
Zheng, Chuansheng

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12876-020-01355-3

URN: urn:nbn:de:101:1-2020082423432972068689

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Chen, Lei
Kan, Xuefeng
Sun, Tao
Ren, Yanqiao
Cao, Yanyan
Yan, Liangliang
Liang, Bin
Xiong, Bin
Zheng, Chuansheng
SpringerLink (Online service)

Other Objects (12)

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Combined Transarterial Chemoembolization and Percutaneous Ablation: A Single-Center Experience

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma

Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE)

Combined Transarterial Chemoembolization and Microwave Ablation Therapy for Hepatocellular Carcinoma: A Randomized Control Study

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Related objects

Reset password